Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE By analyzing 1000 genomes data for East Asian, we identified only one SNP in nearby region, rs402710, in high linkage disequilibrium with rs401681, which was also associated with lung cancer. 29939218

2018

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE We examined the clinicopathological and prognostic value of rs401681 variants in lung cancer. 29033187

2017

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE The rs401681 polymorphism was significantly associated with a decreased risk of lung cancer, bladder cancer, and basal cell carcinoma in Asians and in hospital-based studies. 29254260

2017

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE In conclusion, in males, the TERT rs2736098 and CLPTM1L rs401681 T alleles are the susceptibility factors for developing lung cancer. 28789383

2017

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE As a result, 15 SNPs on or near 12 genes and one miRNA with strong evidence of association with lung cancer risk were identified, including TERT (rs2736098), CHRNA3 (rs1051730), AGPHD1 (rs8034191), CLPTM1L (rs401681 and rs402710), BAT3 (rs3117582), TRNAA (rs4324798), ERCC2 (Lys751Gln), miR-146a2 (rs2910164), CYP1B1 (Arg48Gly), GSTM1 (null/present), SOD2 (C47T), IL-10 (-592C/A and -819C/T), and TP53 (intron 6). 29110844

2017

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE After adjusting for known risk loci, rs2736100 and rs401681, we identified a new, independent lung cancer susceptibility variant in LPCAT1: rs139852726 (OR = 0.46, P = 4.73×10(-9)), and three new adenocarcinoma risk variants in TERT: rs61748181 (OR = 0.53, P = 2.64×10(-6)), rs112290073 (OR = 1.85, P = 1.27×10(-5)), rs138895564 (OR = 2.16, P = 2.06×10(-5); among young cases, OR = 3.77, P = 8.41×10(-4)). 26590902

2016

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE No association was found between CLPTM1L-rs401681 and lung cancer risk. 24861918

2014

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE In conclusion, our study indicated that the CLPTM1L - rs401681 (G>A) polymorphism was significantly associated with decreased lung cancer risk, especially among European populations. 24634236

2014

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE Our findings demonstrated that rs402710 and rs401681 are risk-conferring factors for the development of lung cancer. 24907075

2014

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE In the genetic model analysis, we found rs402710 and rs401681 were associated with decreased lung cancer risk. 25526467

2014

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE Our findings provide further evidence supporting rs401681 as a genetic variant associated with the risk of lung cancer. 24386361

2013

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE We genotyped rs2736100 (TERT) and rs401681 (CLPTM1L) SNPs in a case-control study with 399 lung cancer cases and 466 controls form Taiyuan, China. 23433592

2013

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE The results from our case-control study and meta-analysis provide convincing evidence that rs401681 is significantly associated with lung cancer risk. 23653681

2013

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE The single-nucleotide polymorphisms (SNP) at 5p15 (rs2736100, adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.03-1.67, P = 0.025; rs402710, aOR 0.82, 95% CI 0.69-0.98, P = 0.025; rs401681, aOR 0.82, 95% CI 0.69-0.98, P = 0.026) and at 15q25 (rs2036534, aOR 0.75, 95% CI 0.61-0.93, P = 0.01; rs6495309, aOR 0.81, 95% CI 0.65-1.00, P = 0.052) were significantly associated with lung cancer risk. 22404340

2012

dbSNP: rs401681
rs401681
0.800 GeneticVariation BEFREE We tested rs401681 for association with 16 additional cancer types in over 30,000 cancer cases and 45,000 controls and found association with lung cancer (OR = 1.15, P = 7.2 x 10(-8)) and urinary bladder, prostate and cervix cancer (ORs = 1.07-1.31, all P < 4 x 10(-4)). 19151717

2009

dbSNP: rs380286
rs380286
0.710 GeneticVariation BEFREE Further stratification analysis showed that rs380286 displayed a significantly decreased lung cancer risk (OR=0.65, P=0.041) in the non-drinkers. 25526467

2014

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE By analyzing 1000 genomes data for East Asian, we identified only one SNP in nearby region, rs402710, in high linkage disequilibrium with rs401681, which was also associated with lung cancer. 29939218

2018

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE As a result, 15 SNPs on or near 12 genes and one miRNA with strong evidence of association with lung cancer risk were identified, including TERT (rs2736098), CHRNA3 (rs1051730), AGPHD1 (rs8034191), CLPTM1L (rs401681 and rs402710), BAT3 (rs3117582), TRNAA (rs4324798), ERCC2 (Lys751Gln), miR-146a2 (rs2910164), CYP1B1 (Arg48Gly), GSTM1 (null/present), SOD2 (C47T), IL-10 (-592C/A and -819C/T), and TP53 (intron 6). 29110844

2017

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE Our findings demonstrated that rs402710 and rs401681 are risk-conferring factors for the development of lung cancer. 24907075

2014

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE After that, a number of studies reported that the rs2736100, rs401681, rs402710, and rs31489 polymorphisms at chromosome 5p15 have been implicated in LC risk. 24615522

2014

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE In the genetic model analysis, we found rs402710 and rs401681 were associated with decreased lung cancer risk. 25526467

2014

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE Significant multiplicative interactions were observed between gender and polymorphisms of rs402710, the "T/T" genotype of which was associated with decreased lung cancer risk in male patients (p = 0.016, OR = 0.35, 95 % CI: 0.17-0.73). 25155038

2014

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE The results from our replication study and the meta-analysis provided firm evidence that rs402710 T allele significantly contributed to decreased lung cancer risk, and the case-control study implied that the variant may yield stronger effect on NSCLC and never smokers. 24194831

2013

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE The single-nucleotide polymorphisms (SNP) at 5p15 (rs2736100, adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.03-1.67, P = 0.025; rs402710, aOR 0.82, 95% CI 0.69-0.98, P = 0.025; rs401681, aOR 0.82, 95% CI 0.69-0.98, P = 0.026) and at 15q25 (rs2036534, aOR 0.75, 95% CI 0.61-0.93, P = 0.01; rs6495309, aOR 0.81, 95% CI 0.65-1.00, P = 0.052) were significantly associated with lung cancer risk. 22404340

2012

dbSNP: rs402710
rs402710
0.100 GeneticVariation BEFREE Four independent SNPs (rs2736100, rs402710, rs4488809 and rs4083914), were found to be associated with a risk of lung cancer. 23228068

2012